• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Adicet Bio, Inc. - Common Stock (NQ:ACET)

    8.090 -0.360 (-4.26%)
    Streaming Delayed Price Updated: 10:17 AM EST, Jan 8, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 24,935
    Open 8.340
    Bid (Size) 8.100 (100)
    Ask (Size) 8.260 (100)
    Prev. Close 8.450
    Today's Range 8.075 - 8.400
    52wk Range 7.154 - 17.44
    Shares Outstanding 42,957,586
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Adicet Bio Provides Corporate Update and Highlights Expected 2026 Milestones
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Announces Reverse Stock Split
    From Adicet Bio, Inc.
    Via Business Wire

    Performance

    YTD
    -8.3%
    -8.3%
    1 Month
    -3.5%
    -3.5%
    3 Month
    -45.6%
    -45.6%
    6 Month
    -29.1%
    -29.1%
    1 Year
    -48.5%
    -48.5%

    More News

    Read More
    News headline image
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio to Participate in a Fireside Chat at the Guggenheim 2nd Annual Healthcare Innovation Conference
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio's Lupus Trial Delivers 100% Response, Setting Stage For Phase 2 ↗
    Via Benzinga
    News headline image
    Tuesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Adicet Bio, Inc. Announces $80 Million Registered Direct Offering
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Announces Positive Preliminary Data from ADI-001 Phase 1 Study in Patients with Lupus Nephritis (LN) and Systemic Lupus Erythematosus (SLE)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
    Via Benzinga
    News headline image
    Adicet Bio (ACET) Q2 Loss Widens 3% ↗
    Via The Motley Fool
    News headline image
    Adicet Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio to Participate in a Fireside Chat at the 45th Annual Canaccord Genuity Growth Conference
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Adicet Bio Announces First Systemic Sclerosis (SSc) Patient Dosed in Ongoing Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    Why Block Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket ↗
    Via Benzinga
    News headline image
    Adicet Bio to Participate in a Fireside Chat at the 2025 Jefferies Global Healthcare Conference
    From Adicet Bio, Inc.
    Via Business Wire
    News headline image
    12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
    Via Chartmill
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga

    Frequently Asked Questions

    Is Adicet Bio, Inc. - Common Stock publicly traded?
    Yes, Adicet Bio, Inc. - Common Stock is publicly traded.
    What exchange does Adicet Bio, Inc. - Common Stock trade on?
    Adicet Bio, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Adicet Bio, Inc. - Common Stock?
    The ticker symbol for Adicet Bio, Inc. - Common Stock is ACET on the Nasdaq Stock Market
    What is the current price of Adicet Bio, Inc. - Common Stock?
    The current price of Adicet Bio, Inc. - Common Stock is 8.090
    When was Adicet Bio, Inc. - Common Stock last traded?
    The last trade of Adicet Bio, Inc. - Common Stock was at 01/08/26 10:17 AM ET
    What is the market capitalization of Adicet Bio, Inc. - Common Stock?
    The market capitalization of Adicet Bio, Inc. - Common Stock is 347.53M
    How many shares of Adicet Bio, Inc. - Common Stock are outstanding?
    Adicet Bio, Inc. - Common Stock has 348M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.